|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print February 22, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00396.2001
Submitted on October 11, 2001
Accepted on February 12, 2002
1 Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA
2 Division of Pulmonary Medicine, University Hospital, Bern, Switzerland
3 Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA
4 Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: lware{at}mednet.ucla.edu.
Pretreatment with keratinocyte growth factor (KGF) ameliorates experimentally-induced acute lung injury in rats. Though alveolar epithelial type II cell hyperplasia probably contributes, the mechanisms underlying KGF's protective effect remain incompletely described. Therefore, we tested the hypothesis that KGF given to rats in vivo would enhance alveolar epithelial repair in vitro by non-proliferative mechanisms. 48h after intratracheal instillation of KGF (5mg/kg), alveolar epithelial type II cells were isolated for in vitro alveolar epithelial repair studies. KGF treated cells had markedly increased epithelial repair (96 ± 22%)compared with control cells (p < 0.001). KGF treated cells had increased cell spreading and migration at the wound edge, but no increase in in vitro proliferation compared to control cells. KGF treated cells were more adherent to extracellular matrix proteins and polystyrene. Inhibition of the EGF receptor with tyrosine kinase inhibitors abolished the KGF effect on epithelial repair. In conclusion, in vivo administration of KGF augments the epithelial repair rate of alveolar epithelial cells by altering cell adherence, spreading, and migration and through stimulation of the EGF receptor.
This article has been cited by other articles:
![]() |
L. P. Desai, K. E. Chapman, and C. M. Waters Mechanical stretch decreases migration of alveolar epithelial cells through mechanisms involving Rac1 and Tiam1 Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L958 - L965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Quesnel, S. Marchand-Adam, A. Fabre, J. Marchal-Somme, I. Philip, S. Lasocki, V. Lecon, B. Crestani, and M. Dehoux Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L334 - L343. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Desai, S. E. Sinclair, K. E. Chapman, A. Hassid, and C. M. Waters High tidal volume mechanical ventilation with hyperoxia alters alveolar type II cell adhesion Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L769 - L778. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tillie-Leblond, P. Gosset, R. Le Berre, A. Janin, T. Prangere, A. B. Tonnel, and B. P. H. Guery Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Eur. Respir. J., July 1, 2007; 30(1): 31 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Blijlevens and S Sonis Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis Ann. Onc., May 1, 2007; 18(5): 817 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu and J. I. Sznajder Mechanisms of pulmonary edema clearance Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L685 - L695. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ulrich, M. Stern, M. E. Goddard, J. Williams, J. Zhu, A. Dewar, H. A. Painter, P. K. Jeffery, D. R. Gill, S. C. Hyde, et al. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1179 - L1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Lazar, P. J. Christensen, M. Du, B. Yu, N. M. Subbotina, K. E. Hanson, J. M. Hansen, E. S. White, R. H. Simon, and T. H. Sisson Plasminogen Activator Inhibitor-1 Impairs Alveolar Epithelial Repair by Binding to Vitronectin Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 672 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Geiser, M. Ishigaki, C. van Leer, M. A. Matthay, and V. C. Broaddus H2O2 inhibits alveolar epithelial wound repair in vitro by induction of apoptosis Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L448 - L453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fehrenbach, C. Bube, J. M. Hohlfeld, P. Stevens, T. Tschernig, H. G. Hoymann, N. Krug, and H. Fehrenbach Surfactant Homeostasis Is Maintained In Vivo during Keratinocyte Growth Factor-induced Rat Lung Type II Cell Hyperplasia Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1264 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Workalemahu, M. Foerster, C. Kroegel, and R. K. Braun Human {gamma}{delta}-T Lymphocytes Express and Synthesize Connective Tissue Growth Factor: Effect of IL-15 and TGF-{beta}1 and Comparison with {alpha}{beta}-T Lymphocytes J. Immunol., January 1, 2003; 170(1): 153 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay, S. Bhattacharya, D. Gaver, L. B. Ware, L. H. K. Lim, O. Syrkina, F. Eyal, and R. Hubmayr Ventilator-induced lung injury: in vivo and in vitro mechanisms Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L678 - L682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |